The Involvement of Adhesion Molecules in the Biology of Multiple Myeloma

References

• Uckun F. M. Regulation of human B-cell ontogeny. Blood 1990; 76: 1908–1923
   PubMed Web of Science ®Google Scholar
• Gallagher R. B., Osmond D. G. To B or not to B: that is the question. Immunol. Today 1991; 12: 1–3
   PubMedGoogle Scholar
• MacLennan I. C. M., Gray L). Antigen-driven selection of virgin and memory B cells. Immunol. Rev. 1986; 91: 61–85
   PubMed Web of Science ®Google Scholar
• Ho F., Hortan J. E., MacLennan I. C. M., Khan M. Distinct short-lived and long-lived antibody producing cell populations. Eur. J. Immunol. 1986; 16: 1297–1301
   PubMed Web of Science ®Google Scholar
• MacLennan I. C. M., Lieu Y. J., Oldfield S., Zhang J., Lane P. J. L. The evolution of B cell clones. Current topics in Microbiol. Immunol. 1990; 159: 37–60
   PubMed Web of Science ®Google Scholar
• Tonegawa S. Somatic generation of antibody diversity. Nature 1983; 302: 575–581
   PubMed Web of Science ®Google Scholar
• Manser T. Evolution of antibody structure during the immune response: the differentiative potential of a single B lymphocyte. J. Exp. Med. 1989; 170: 1211–1230
   PubMed Web of Science ®Google Scholar
• Liu Y. J., Joshua D. E., Williams G. T., Smith C. A., Gordon J., MacLennan I. C. M. The mechanism of antigen-driven selection in germinal centres. Nature 1989; 342: 929–931
   PubMed Web of Science ®Google Scholar
• Benner R., Hijmans W., Haaijman J. J. The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin. exp. Immunol. 1981; 46: 1–8
   PubMed Web of Science ®Google Scholar
• van Camp B. Clinical and experimental studies on the nature of monoclonal gammopathies. Free University Brussels. 1980, Ph. D thesis
   Google Scholar
• Foon K. A., Schroff R. W., Gale R. P. Surface markers on leukemia and lymphoma cells: recent advances. Blood 1982; 60: 1–19
   PubMed Web of Science ®Google Scholar
• Foon K. A., Todd R. F. Immunological classification of leukemia and lymphoma. Blood 1986; 68: 1–31
   PubMed Web of Science ®Google Scholar
• Mellstedt H., Holm G., Björkholm M. Multiple Myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy: characteristics of the B cell clone, immunoregulatory cell populations and clinical implications. Advances in Cancer Research 1984; 41: 257–262
   PubMed Web of Science ®Google Scholar
• Fu S. M., Winchester R. J., Feizi T., Walzer P. D., Kunkel H. G. Idiotype specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proc. Nat. Acad. Sci. 1974; 71: 4487–4490
   PubMed Web of Science ®Google Scholar
• Sato I., Abo T., Onodera S., Kumagai K. Detection of monoclonal B lymphocytes in multiple myeloma by immunofluorescence tests of surface immunoglobulines. Scand. J. Haematol. 1978; 21: 433–444
   PubMedGoogle Scholar
• Bast E. J. E. G., van Camp B., Reynaert P., Wiringa G., Ballieux R. E. Idiotypic peripheral blood lymphocytes in monoclonal gammopathy. Clin. exp. Immunol. 1982; 47: 677–682
   PubMed Web of Science ®Google Scholar
• van Riet I., Heirman C., Lacor P., De Waele M., Thielemans K., van Camp B. Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies. Br. J. Haematol. 1989; 73: 289–295
   PubMed Web of Science ®Google Scholar
• Berenson J., Wong R., Kim K., Brown N., Lichtenstein A. Evidence for peripheral blood B lymphocytes but not T lymphocyte involvement in multiple myeloma. Blood 1987; 70: 1550–1553
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Bergui L., Tesio L., Pizollo G., Malavasi F., Chilosi M., Campana D., van Camp B., Janossy G. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J. Clin. Invest. 1985; 76: 1243–1251
   PubMed Web of Science ®Google Scholar
• Bergui L., Schena N., Gaidano G., Riva M., Caligaris-Cappio F. Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cells precursors in multiple myeloma. J. Exp. Med. 1989; 170: 613–618
   PubMed Web of Science ®Google Scholar
• Grogan T. M., Dune B. G. M., Spier C. M., Richter L., Vela E. Myelomonocytic antigen positive multiple myeloma. Blood 1989; 73: 763–769
   PubMed Web of Science ®Google Scholar
• Epstein J., Xiao H., He X. -Y. Markers of multiple hematopoietic-cell lineages in multiple myeloma. N. Engl. J. Med. 1990; 322: 664–668
   PubMed Web of Science ®Google Scholar
• Petruch U. R., Horny H. P., Kaiserling E. Frequent expression of haematopoietic and non-haematopoietic antigens by neoplastic plasma cells: an immunohistochemical study using formalin-fixed, paraffin-embedded tissue. Histopathology 1992; 20: 35–40
   PubMed Web of Science ®Google Scholar
• Epstein J. Myeloma phenotype : clues to disease origin and manifestation. Hematology/ Oncology clinics of North America 1992; 6: 249–256
   PubMed Web of Science ®Google Scholar
• Warburton P., Joshua D. E., Gibson J., Brown R. D. CD10–(CALLA)-positive lymphocytes in myeloma: evidence that they are a malignant precursor population and are of germinal centre origin. Leukemia and Lymphoma 1989; 1: 11–20
   PubMedGoogle Scholar
• Joshua D. E., Ionnidis R., Brown R., Francis S. E., Gibson J., Kronenberg H. Multiple myeloma: the relationship between light chain isotype suppression, labeling index of plasma cells and CD38 expression or peripheral blood lymphocytes. Amer. J. Hematol. 1988; 29: 5–12
   PubMed Web of Science ®Google Scholar
• Shimazaki C., Fried J., Perez A. G., Scheinberg D. A., Atzpodien J., Wang C. Y., Wisniewolski R., Clarkson B. D. Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma. Acta Haematol. 1990; 83: 123–129, 1990
   PubMed Web of Science ®Google Scholar
• Bakkus M. H. C., Heirman G, Van Riet I., Van Camp B., Thielemans K. Evidence that multiple myeloma immunoglobulin heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 1992, (in press).
   PubMed Web of Science ®Google Scholar
• Williams A. F., Barclay A. N. The immunoglobulin superfamily-domains for cell recognition. Annu. Rev. Immunol. 1988; 6: 381–405
   PubMed Web of Science ®Google Scholar
• Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu. Rev. Biochem. 1990; 59: 237–252
   PubMed Web of Science ®Google Scholar
• Hynes R. O. Integnns: a family of cell surface receptors. Cell 1987; 48: 549–554
   PubMed Web of Science ®Google Scholar
• Lasky L. A. Lectin cell adhesion molecules (LEC-CAMS): a new family of cell adhesion proteins involved with inflammation. J. Cell. Biochem. 1991; 45: 139–146
   PubMed Web of Science ®Google Scholar
• Stoolman L. M. Adhesion molecules controlling lymphocyte migration. Cell 1989; 56: 907–910
   PubMed Web of Science ®Google Scholar
• Murakami S., Miyake K., Kincade P. W., Hodes R. J. Functional role of CD44 (Pgp-1) on activated B cells. Immunol. Res. 1991; 10: 15–27
   PubMed Web of Science ®Google Scholar
• Billips L. G., Petitte D., Dorschkind K., Narayanan R., Chiu C. P., Landreth K. S. Differential roles of stromal cells, interleukin 7, and ckit-ligand in the regulation of B lymphopoiesis. Blood 1992; 79: 1185–1192
   PubMed Web of Science ®Google Scholar
• Dorshkind K., Landreth K. S. Regulation of B cell differentiation by bone marrow stromal cells. Int. J. Cell cloning 1992; 10: 12–17
   PubMedGoogle Scholar
• Ryan D. H., Nuccie B. L., Abboud C. N., Winslow J. M. Vascular adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. J. Clin. Invest. 1991; 88: 995–1004
   PubMed Web of Science ®Google Scholar
• Picker L. J. Physiological and molecular mechanisms of lymphocyte homing. Annu. Rev. Immunol. 1992; 10: 561–591
   PubMed Web of Science ®Google Scholar
• Jalkanan S., Bartgatze R. F., de loss Toyos J., Butcher E. C. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85–95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal or synovial endothelial cells. J. Cell. Biol. 1987; 105: 983–990
   PubMed Web of Science ®Google Scholar
• Holzmann B., Weissman I. L. Integrin molecules involved in lymphocyte homing to Peyer's patches. Immunological reviews 1989; 108: 45–61
   PubMed Web of Science ®Google Scholar
• Hamann A., Jablonski-Westrich D., Duijvestijn A., Butcher E. C., Baisch H., Harder R., Thiele R. Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing. J. Immunol. 1988; 140: 693–699
   PubMed Web of Science ®Google Scholar
• Koopman G., Parmentier H. K., Schuurman H. J., Newman W., Meijer C. J. L. M., Pals S. T. Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways. J. Exp. Med. 1991; 173: 1297–1304
   PubMed Web of Science ®Google Scholar
• Pals S. T., Horst E., Ossekoppele G., Fidgor C. G., Scheper R. J., Meijer C. J. L. M. Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood 1989; 73: 885–888
   PubMed Web of Science ®Google Scholar
• Jalkanen S., Joensuu H., Sodestrom K. -O., Klemi P. Lymphocyte homing and clinical behaviour of non-Hodgkin's lymphoma. J. Clin. Invest. 1991; 87: 1835–1840
   PubMed Web of Science ®Google Scholar
• Pals S. T., Meijer C. J. L. M., Radaszkiewicz T. Expression of the human peripheral lymph node homing receptor (LECAM-1) in nodal and gastrointestinal non-Hodgkin's Lymphomas. Leukemia 1991; 5: 628–631
   PubMed Web of Science ®Google Scholar
• Boyd A. W., Dunn S. M., Fecondo J. V., Culvenor J. G., Duhrsen U., Burns G. F., Wawryk S. O. Regulation of expression of human intercellular adhesion molecule (ICAM-1) during lympho-hematopoietic differentiation. Blood 1989; 73: 1896–1903
   PubMed Web of Science ®Google Scholar
• Stauder R., Greil R., Schulz T. F., Thaler J., Gattringer C., Radaszkiewicz T., Dierich M. P., Huber H. Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin's lymphomas and leukemias: possible influence on growth pattern and leukemic behaviour. Clin. exp. Immunol. 1989; 77: 234–238
   PubMed Web of Science ®Google Scholar
• Horst E., Meijer C. J. L. M., Radaszkiewicz T., Ossekoppele G. J., Van Krieken J. H. J. M., Pals S. T. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18) and ICAM-1 (CD54). Leukemia 1990; 4: 595–599
   PubMed Web of Science ®Google Scholar
• Aiello A., Delia D., Fontanella E., Giardini R., Rilke F., Della Porta G. Expression of differentiation and adhesion molecules in sporadic Burkitt's lymphoma. Hematological Oncology 1990; 8: 229–238
   PubMed Web of Science ®Google Scholar
• Medeiros L. J., Weiss L. M., Picker L. J., Clayberger C., Horning S. J., Krensky A. M., Warnke R. A. Expression of LFA-1 in Non-Hodgkin's Lymphoma. Cancer 1989; 63: 255–259
   PubMed Web of Science ®Google Scholar
• Kansas G. S., Dailey M. O. Expression of adhesion structures during B cell development in man. J. Immunol. 1989; 142: 3058–3062
   PubMed Web of Science ®Google Scholar
• Ballard L. L., Brown E. J., Holers V. M. Expression of the fibronectin receptor VLA-5 is regulated during human B cell differentiation and activation. Clin. exp. Immunol. 1991; 84: 336–346
   PubMed Web of Science ®Google Scholar
• Horst E., Meijer C. J. L. M., Radaskiewicz T., Van Dongen J. J. M., Pieters R., Figdor C. G., Hooftman A., Pals S. T. Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development. Leukemia 1990; 4: 383–389
   PubMed Web of Science ®Google Scholar
• Zhang X. G., Klein B., Bataille R. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood 1989; 74: 11–13
   PubMed Web of Science ®Google Scholar
• Bataille R., Jourdan M., Zhang X. -G., Klein B. Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J. Clin. Invest. 1989; 84: 2008–2011
   PubMed Web of Science ®Google Scholar
• Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H., Kuramoto A., Kishimato T. Autocrine generation and requirement of BSF-2/IL6 for human multiple myelomas. Nature 1988; 332: 83–85
   PubMed Web of Science ®Google Scholar
• Klein B., Zhang X-G., Jourdan M., Content J., Houssiau F., Aarden L., Piechaczyck M., Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989; 73: 517–526
   PubMed Web of Science ®Google Scholar
• Nillson K., Jernberg H., Petterson M. IL6 as a growth factor for human myeloma cells—a short “overview”. Current Topics of Microbiology and Immunology 1990; 166: 3–12
   PubMed Web of Science ®Google Scholar
• Klein B., Bataille R. Cytokine network in human multiple myeloma. Hematology/Oncology clinics of Northern America 1992; 6: 273–284
   PubMed Web of Science ®Google Scholar
• Cozzolino F., Torcia M., Aldinucci D., Rubartelli A., Miliani A., Shaw A. R., Landsdorp P. M., Di Guglielmo R. Production of interleukin-1 by bone marrow myeloma cells. Blood 1989; 74: 380–387
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek A., Belch A. R., Jacobs A., Bowen D., Padua R. A., Paietta E., Stanley E. R. Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia and lymphoid malignancies. Blood 1991; 77: 1796–1803
   PubMed Web of Science ®Google Scholar
• Bakkus M. H. C., Brakel-van Peer K. M. J., Adriaansen H. J., van den Akker T. W., Benner R. Detection of interleukin-1b˜ and interleukin-6 expression in human multiple myeloma by fluorescent in situ hybridization. Leukemia and Lymphoma 1991; 4: 389–395
   PubMed Web of Science ®Google Scholar
• Nakamura M., Merchav S., Carter A., Ernst T. J., Demetri G. D., Furukawa Y., Anderson K., Freedman A. S., Griffin J. D. Expression of a novel 3.5 kb macrophage colony-stimulating factor transcript in human myeloma cells. J. Immunol. 1989; 143: 3543–3547
   PubMed Web of Science ®Google Scholar
• Van Riet I., De Waele M., Remels L., Lacor P., Schots R., Van Camp B. Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells. Br. J. Haematol. 1991; 79: 421–427
   PubMed Web of Science ®Google Scholar
• Van Riet I., De Waele M., Schots R., Lacor P., Van Camp B. The expression of cytoadhesion molecules in normal and malignant plasma cells. 'Monoclonal gammopathies III'. Clinical significance and basic mechanisms, J. Radl, B. Van Camp, 1991; 75–78
   Google Scholar
• Roldan E., Garcia-Pardo A., Brieva J. A. VLA-4 fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion. J. Exp. Med. 1992; 175: 1739–1747
   PubMed Web of Science ®Google Scholar
• Barker H. F., Hamilton M. S., Ball J., Drew M., Franklin I. M. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells. Br. J. Haematol. 1992; 81: 331–335
   PubMed Web of Science ®Google Scholar
• Horst E., Radaskiewicz T., Hooftman-den Otter A., Pieters R., Van Dongen J. J. M., Meijer C. J. L. M., Pals S. T. Expression of the leucocyte integrin LFA-1 (CD11a/ CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumour grade. Leukemia 1991; 5: 848–853
   PubMed Web of Science ®Google Scholar
• Kawano M. M., Huang N., Tanaka H., Ishikawa H., Sakai A., Tanabe O., Nobuyoshi M., Kuramoto A. Homotypic cell aggregations of human myeloma cells with ICAM-1 and LFA-1 molecules. Br. J. Haematol. 1991; 79: 583–588
   PubMed Web of Science ®Google Scholar
• Ahsmann E. J. M., Lokhorst H. M., Dekker A. W., Bloem A. C. Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma. Blood 1992; 79: 2068–2075
   PubMed Web of Science ®Google Scholar
• Bloem A. C., Lokhorst H. M., De Gruyl T. D., Dekker A. W., Ahsmann E. J. M. Studies on molecules involved in adhesion of plasma cells. 'Monoclonal gammopathies III Clinical significance and basic mechanisms', J. Radl, B. Van Camp, 1991; 71–73
   Google Scholar
• Pilarski L. M., Jensen G. S. Monoclonal circulating B cells in Multiple Myeloma : a continuously differentiating, possibly invase, populating, as defined by expression of CD45 isoforms and adhesion molecules. Hematology/Oncology Clinics in North America 1992; 6: 297–322
   PubMed Web of Science ®Google Scholar
• Osborn L. Leucocyte adhesion to endothelium in inflammation. Cell 1990; 62: 3–6
   PubMed Web of Science ®Google Scholar
• Van Camp B., Dune B. G. M., Spier C., De Waele M., Van Riet I., Vela E., Frutiger Y., Richter L., Grogan T. M. Plasma cells in multiple myeloma express a natural killer cell associated antigen: CD56 (NKH-1; Leu 19). Blood 1990; 76: 377–382
   PubMed Web of Science ®Google Scholar
• Drach J., Gattringer C., Huber H. Expression of the neural cell adhesion molecule (CD56) by human myeloma cells. Clin. exp. Immunol. 1991; 83: 418–422
   PubMed Web of Science ®Google Scholar
• Leo R., Boeker M., Peest D., Hein R., Bartl R., Gessner J. E., Selbach J., Wacker G., Deichner H. Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56 +, CD54 +, clg+ is the common phenotype of myeloma cells. Ann. Hematol. 1992; 64: 132–139
   PubMed Web of Science ®Google Scholar
• Doherty P., Cohen J., Walsh F. S. Neurite outgrowth in response to transfected NCAM changes during development and is modulated by polysialic acid. Neuron 1990; 5: 209–219
   PubMed Web of Science ®Google Scholar
• Walsh F. S., Dickson G. Generation of multiple N-CAM polypeptides from single gene. Bio Essays 1989; 11: 83–88
   PubMed Web of Science ®Google Scholar
• Carbone D. P., Koroo A. M. C., Linnonoila R. I., Jewett P., Gazdar A. F. Neural cell adhesion molecule expression and messenger RNA splicing patterns in lung cancer cell lines are correlated with neuroendocrine phenotype and growth morphology. Cancer Research 1991; 51: 6142–6149
   PubMed Web of Science ®Google Scholar
• Roth J., Zuber C., Wagner P., Taatjes D. J., Weisgerber C., Heitz P. U., Goridis C., Bitter-Suermann D. Reexpression of poly (sialic acid) units of the neural cell adhesion molecule in Wilms tumor. Proc. Natl. Acad. Sci. 1988; 85: 2999–3003
   PubMed Web of Science ®Google Scholar
• Lipinski M., Hirsch M. R., Deagostini-Bazin H., Yamada O., Tursz T., Goridis C. Characterization of neural cell adhesion molecules (N-CAM) expressed by Ewing and neuroblastoma cell lines. Inr. J. Cancer 1987; 40: 81–86
   PubMed Web of Science ®Google Scholar
• Figarella-Branger D. F., Durbec P. L., Rougon G. N. Differential spectrum of expression of neural cell adhesion molecule isoforms and L1 adhesion molecules on human neuroectodermal tumors. Cancer Research 1990; 50: 6364–6370
   PubMed Web of Science ®Google Scholar
• Reuss-Borst M. A., Steinke B., Walks H. D., Bühring H. J., Müller C. A. Phenotypic and clinical heterogeneity of CD56-positive acute non lymphoblastic leukemia. Ann. Hematol. 1992; 64: 78–82
   PubMed Web of Science ®Google Scholar
• Durie B. G. M. Staging and kinetics of multiple myeloma. Semin. Oncol. 1986; 163: 300–309
   Google Scholar
• Cunningham B. A., Hemperly J. J., Murray B. A., Prediger E. A., Brackenburg R., Edelman G. M. Neural cell adhesion molecule : structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science 1987; 236: 799–806
   PubMed Web of Science ®Google Scholar
• Nguyen C., Mattei M. G., Mattei J. F., Santoni M. J., Goridis C., Jordan B. R. Localization of the human NCAM gene to band q23 of chromosome 11 : the third gene coding for a cell interaction molecule napped to the distal portion of the long arm of chromosome 11. J. Cell. Biol. 1986; 102: 711–715
   PubMed Web of Science ®Google Scholar
• Reyes A. A., Small S. J., Akeson R. At least 27 alternatively spliced forms of the neural cell adhesion molecule mRNA are expressed during at least development. Mol. Cell. Biol., 11: 1654–1661
   PubMed Web of Science ®Google Scholar
• Santoni M. J., Barthels D., Vopper G., Bonded A., Goridis C., Wille W. Differential exon usage involving an unusual splicing mechanism generates at least eight types of N-CAM cDNA in mouse brain. EMBO 1989; 8: 385–392
   PubMed Web of Science ®Google Scholar
• Remels L., Bakkus M., Van Riet I., Van Camp B., Thielemans K. Molecular characterization of N-CAM (CD56, leu-19) expression in Multiple Myeloma. Monoclonal gammopathies III linical significance and basic mechanisms, J. Radl, B. Van Camp, 1991; 67–70
   Google Scholar
• Dustin M. L., Rothlein R., Bhan A. K., Dinarello C. A., Springer T. A. Induction by IL1 and interferon γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 1986; 137: 245–254
   PubMed Web of Science ®Google Scholar
• Rousset F., Billaud M., Blanchard D., Figdor C., Lenoir G. M., Spits H., De Vries J. E. IL4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines: requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesion. J. Immunol. 1989; 143: 1490–1498
   PubMed Web of Science ®Google Scholar
• Roubin R., Deagostini-Bazin H., Hirsch M. -R., Goridis C. Modulation of N-CAM expression by transforming growth factor-beta, serum, and autocrine factors. J. Cell. Biol. 1990; 111: 673–684
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Gregoretti M. G., Ghia P., Bergui L. In vitro growth of human multiple myeloma: implications for biology and therapy. Hematology/Oncology clinics in North America 1992; 6: 257–271
   PubMed Web of Science ®Google Scholar
• Husmann M., Gorgen I., Weisgerber C., Bitter-Suermann D. Upregulation of embryonic NCAM in an EC cell line by retinoic acid. Dev. Biol. 1989; 136: 194–200
   PubMed Web of Science ®Google Scholar
• Lacor P., Van Riet I., Jochmans K., De Waele M., Van Camp B. Expression of the adhesion molecule N-CAM (CD56, Leu 19) in plasma cell dyscrasias is correlated to biologic behaviour and clinical evolution of the disease. 1992, (in preparation).
   Google Scholar
• Andersson A. M., Moran N., Gaardsvoll H., Linnemann D., Bjerkvig R., Laerum O. D., Bock E. Characterization of N-CAM expression and function in BT4C and BT4Cn glioma cells. Int. J. Cancer 1991; 47: 124–129
   PubMed Web of Science ®Google Scholar
• Rutishauer U., Acheson A., Hall K., Mann D. M., Sunshine J. The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science 1988; 240: 53–57
   PubMed Web of Science ®Google Scholar
• Ide G. J., Burg M. Characterization of heparan sulfate proteoglycan that copurifies with the neural cell adhesion molecule. Exp. Cell. Res. 1989; 182: 44–60
   PubMed Web of Science ®Google Scholar
• Morris A. J., Turnbull J. E., Riley G. P., Gordon M. Y., Gallagher J. T. Production of heparan sulphate proteoglycans by human bone marrow stromal cells. J. Cell. Science 1991; 99: 149–156
   PubMed Web of Science ®Google Scholar